BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31764001)

  • 1. Preventing Ovarian Cancer in High-risk Women: One Surgery at a Time.
    Swanson CL; Bakkum-Gamez JN
    Clin Obstet Gynecol; 2020 Mar; 63(1):64-73. PubMed ID: 31764001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers.
    Reitsma W; Mourits MJ; de Bock GH; Hollema H
    Mod Pathol; 2013 Apr; 26(4):572-8. PubMed ID: 23080033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term outcomes for single-port risk-reducing salpingo-oophorectomy with and without hysterectomy for women at risk for gynecologic cancer.
    Carr CE; Chambers L; Jernigan AM; Freeman L; Escobar PF; Michener CM
    Int J Gynecol Cancer; 2021 Feb; 31(2):215-221. PubMed ID: 32948638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical decision making in premenopausal
    Gaba F; Goyal S; Marks D; Chandrasekaran D; Evans O; Robbani S; Tyson C; Legood R; Saridogan E; McCluggage WG; Hanson H; Singh N; Evans DG; Menon U; Manchanda R;
    J Med Genet; 2022 Feb; 59(2):122-132. PubMed ID: 33568437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?
    Boerner T; Long Roche K
    J Minim Invasive Gynecol; 2021 Mar; 28(3):403-408. PubMed ID: 33038519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.
    Moldovan R; Keating S; Clancy T
    Fam Cancer; 2015 Mar; 14(1):51-60. PubMed ID: 25342222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.
    Finch A; Metcalfe K; Lui J; Springate C; Demsky R; Armel S; Rosen B; Murphy J; Elit L; Sun P; Narod S
    Clin Genet; 2009 Mar; 75(3):220-4. PubMed ID: 19263514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
    Shaw PA; Clarke BA
    Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk.
    Harmsen MG; IntHout J; Arts-de Jong M; Hoogerbrugge N; Massuger LFAG; Hermens RPMG; de Hullu JA
    Obstet Gynecol; 2016 Jun; 127(6):1054-1063. PubMed ID: 27159752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
    Kwon JS; Tinker A; Pansegrau G; McAlpine J; Housty M; McCullum M; Gilks CB
    Obstet Gynecol; 2013 Jan; 121(1):14-24. PubMed ID: 23232752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for estimating ovarian cancer risk: application for preventive oophorectomy.
    Giannakeas V; Sopik V; Shestopaloff K; Iqbal J; Rosen B; Akbari M; Narod SA
    Gynecol Oncol; 2015 Nov; 139(2):242-7. PubMed ID: 26341709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
    Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
    Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
    Ludwig KK; Neuner J; Butler A; Geurts JL; Kong AL
    Am J Surg; 2016 Oct; 212(4):660-669. PubMed ID: 27649974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.
    Grandi G; Sammarini M; Cortesi L; Toss A; Botticelli L; Varliero F; Sighinolfi G; Barbieri E; Facchinetti F
    Menopause; 2021 Feb; 28(3):263-270. PubMed ID: 33534430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exclusive salpingectomy or prophylactic salpingo-oophorectomy? Critical analysis of the latest French guidelines].
    Chene G; Lamblin G
    Gynecol Obstet Fertil Senol; 2018 Jan; 46(1):1-3. PubMed ID: 29203396
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
    Steenbeek MP; van Bommel MHD; Harmsen MG; Hoogerbrugge N; van Doorn HC; Keurentjes JHM; van Beurden M; Zweemer RP; Gaarenstroom KN; Penders CGJ; Brood-van Zanten MMA; Vos MC; Piek JM; van Lonkhuijzen LRCW; Apperloo MJA; Coppus SFPJ; IntHout J; de Hullu JA; Hermens RPMG
    Gynecol Oncol; 2021 Nov; 163(2):371-377. PubMed ID: 34456057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.
    Foretová L; Navrátilová M; Svoboda M; Vašíčková P; Sťahlová EH; Házová J; Kleiblová P; Kleibl Z; Macháčková E; Palácová M; Petráková K
    Klin Onkol; 2019; 32(Supplementum2):6-13. PubMed ID: 31409076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.